Betamethasone Dipropionate Ointment, Augmented
Product Images NDC 35573-107

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Betamethasone Dipropionate (NDC 35573-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Burel Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel (15 g Tube Label)

Package Label.principal Display Panel (15 g Tube Label)
Betamethasone Dipropionate Ointment is a prescription medication used for topical application only. It contains 0.05% betamethasone dipropionate, which is a corticosteroid. The ointment should not be used orally, in the eyes, or vaginally. Each gram of the ointment contains 0.643 mg of betamethasone dipropionate. The usual dosage involves applying a thin layer of the ointment once or twice daily to the affected skin without covering it. Treatment with Betamethasone Dipropionate Ointment should not exceed 50 g per week. The medication should be stored at a temperature between 20°C to 25°C, with excursions permitted to 15°C to 30°C. The manufacturing information includes the manufacturer, APL Health Care Limited in India, and Burel Pharmaceuticals, LLC in the USA.*
FDA Label Image

Package Label.principal Display Panel (15 g Tube Carton Label)

Package Label.principal Display Panel (15 g Tube Carton Label)
This appears to be a description of a pharmaceutical product - Betamethasone Dipropionate Ointment. The text includes information about the strength, usage, NDC number, dosage instructions, ingredients, storage conditions, manufacturer details, and regulatory information. The product is indicated for topical use only and contains betamethasone dipropionate as the active ingredient. It is important to follow the prescribing information and store the ointment within the recommended temperature range.*
FDA Label Image

Package Label.principal Display Panel (50 g Tube Label)

Package Label.principal Display Panel (50 g Tube Label)
This is a description of Betamethasone Dipropionate ointment, USP (Augmented) 0.05%. It is indicated for topical use only and should not be used orally, in the eyes, or intravaginally. Each gram contains 0.643 mg of betamethasone dipropionate, equivalent to 0.5 mg of betamethasone, in a white to off-white ointment base. The usual dosage involves applying a thin film of the ointment once or twice daily without covering the skin. Usage should be limited to 50g per week. The product should be stored at 20° to 25°C with excursions allowed between 15° to 30°C. The packaging includes lot number and expiry date information. This medication is manufactured by APL Health Care Limited in India and distributed by Burel Pharmaceuticals in the USA.*
FDA Label Image

Package Label.principal Display Panel (50 g Tube Carton Label)

Package Label.principal Display Panel (50 g Tube Carton Label)
This is a label for Betamethasone Dipropionate Ointment, USP (Augmented) with 0.05% strength. The ointment is for topical use only and should not be used orally, ophthalmically, or intravaginally. Each gram contains 0.643 mg betamethasone dipropionate USP. The recommended dosage is to apply a thin layer of the ointment to the affected skin once or twice daily. Storage instructions are provided. The label also includes details about NDC, Rx only, and the manufacturer information. This label contains variable data and a unique serial number on each carton.*
FDA Label Image

Str (Betamethasonestr)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.